Developer docs
API playgroundTry for free, no card

Search company profiles

WeMed

Full company profile

uuid0002pn9

Namestring
WeMed
Legal namestring
Beijing WeMed Medical Technology Co., Ltd. (北京唯迈医疗科技股份有限公司)
Websiteurl
we-med.com
Company typeenum
Private
Founded yearint
2014
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersBeijing, China
HQ citystring
Beijing
HQ countrystring
China
HQ regionstring
Asia
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
interventional imaging systems, surgical robotics, vascular angiography equipment, interventional cardiology devices, AI medical imaging
Industry5 codes
PRIMARYHLAHADAF
Surgical Robotics & Computer-Assisted Surgery Platforms
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SECONDARYHLAHAEAL
Surgical Navigation, Robotics & Patient-Matched Instrumentation (Ortho/Spine)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Implants & Prosthetics (Orthopedic/Neuro/Spine/Dental)
SECONDARYHLAHADAH
Intraoperative Imaging & Guidance (C-arms, O-arm, IOUS, fluorescence)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SECONDARYHDAAAEAH
Medical Imaging AI
SECONDARYHDAAAIAC
Healthcare & Assistive Robotics
NAICS code4 codes
  • Surgical and Medical Instrument Manufacturing339112
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Navigational, Measuring, Electromedical, and Control Instruments Manufacturing33451
  • Medical Equipment and Supplies Manufacturing3391
SIC code3 codes
  • Surgical & Medical Instruments & Apparatus3841
  • Electromedical & Electrotherapeutic Apparatus3845
  • Search, Detection, Navagation, Guidance, Aeronautical Sys3812
Product category
Interventional Medical Imaging Equipment
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Supply Chain, Technology or R&D, Marketing or Sales, Operations
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

WeMed designs and manufactures interventional medical imaging equipment and surgical robotics, including vascular angiography X-ray systems, mobile C-arms, coronary interventional surgery control systems, and interventional surgical robots, paired with an AI-based medical image processing software platform. Its products are used by hospitals and clinical centers to perform image-guided cardiovascular, neurointerventional, peripheral vascular, digestive, OB/GYN, and orthopedic procedures.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

WeMed is a medical technology company specializing in interventional robotics and medical imaging solutions. The product portfolio centers on interventional surgical control systems and medical vascular angiography X-ray machines across multiple series (Taikon太空, Pilot/Polaris, Phoenix, Elfinbot). The company also offers AI-powered image processing software (PrecisionSuit100) that integrates with their imaging hardware. Solution categories include cardiovascular imaging, neurointerventional imaging, digestive intervention, obstetrics/gynecology low-dose solutions, and orthopedic HD fluoroscopy. The flagship product ETcath200 represents their interventional robotics capability with intelligent guide wire control and resistance sensing.

Product and service1 record
1ETcath200 Coronary Interventional Surgery Control System
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Global leader in interventional imaging (Artis angiography systems) and acquired Corindus, a vascular interventional robotics company. WeMed competes head-to-head in the same interventional cardiology and angiography categories with its ETcath200 and Pilot/Taikon systems.

TypeBroad incumbent
Description

Operates the Innova interventional angiography platform and broad imaging portfolio. Directly competes with WeMed's Pilot3000 and Taikon series in hospital interventional suites, and competes on AI-enabled image processing capabilities.

TypeBroad incumbent
Description

Markets the Azurion image-guided therapy platform and integrated interventional cardiology suites. Competes with WeMed in angiography hardware, image guidance, and increasingly in procedural AI software.

TypeDirect peer
Description

Developer of robotic magnetic navigation systems for cardiac ablation and interventional procedures. WeMed's ETcath200 robotic guide wire control system competes in the same interventional robotics category for catheter-based procedures.

TypeDirect peer
Description

French developer of the R-One robotic platform for coronary angioplasty. WeMed's ETcath200 coronary interventional control system competes in the same vascular interventional robotics space.

TypeBroad incumbent
Description

Major angiography and interventional imaging manufacturer (Alphenix series). Directly competes with WeMed's interventional X-ray and angiography systems in hospital catheterization labs.

7Neusoft Medical Systems
TypeRegional player
Description

Chinese medical imaging manufacturer with angiography and CT product lines. Closest domestic competitor to WeMed's interventional imaging portfolio, competing for the same Chinese hospital customers.

TypeRegional player
Description

China-based high-end medical imaging and interventional equipment manufacturer. Competes with WeMed in angiography, mobile C-arms, and increasingly in AI-enabled imaging software for Chinese hospitals.

TypeRegional player
Description

Large Chinese medical device company with expanding imaging and interventional offerings. Competes with WeMed across multiple Chinese hospital departments and has greater scale in sales and service infrastructure.

TypeEmerging player
Description

US-based interventional thrombectomy and vascular robotics company (with REAL System). Competes with WeMed in neurovascular and peripheral vascular interventional procedures where image-guided therapy and robotic precision are key buying criteria.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability2 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds4 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors11 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

WeMed

Interventional Medical Imaging Equipmentwe-med.com

WeMed firmographics

Firmographics
Name
WeMed
Legal name
Beijing WeMed Medical Technology Co., Ltd. (北京唯迈医疗科技股份有限公司)
Website
https://we-med.com
Company type
Private
Founded year
2014
Operating status
Operating
Headcount range
1–10 employees
Ownership category
akta.pro rank

WeMed industry classification

Industry
Product category
Interventional Medical Imaging Equipment
NAICS
Surgical and Medical Instrument Manufacturing (339112), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451), Medical Equipment and Supplies Manufacturing (3391)
SIC
Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845), Search, Detection, Navagation, Guidance, Aeronautical Sys (3812)
akta.pro industry
PRIMARYHLAHADAF
Surgical Robotics & Computer-Assisted Surgery Platforms
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SECONDARYHLAHAEAL
Surgical Navigation, Robotics & Patient-Matched Instrumentation (Ortho/Spine)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Implants & Prosthetics (Orthopedic/Neuro/Spine/Dental)
SECONDARYHLAHADAH
Intraoperative Imaging & Guidance (C-arms, O-arm, IOUS, fluorescence)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SECONDARYHDAAAEAH
Medical Imaging AI
SECONDARYHDAAAIAC
Healthcare & Assistive Robotics

Keywords

  • Interventional imaging systems
  • Surgical robotics
  • Vascular angiography equipment
  • Interventional cardiology devices
  • AI medical imaging

Where WeMed is headquartered

Location

Headquarters

HQ city
Beijing
HQ country
China
HQ region
Asia

Offices1 record

Markets served

WeMed business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Supply Chain, Technology or R&D, Marketing or Sales, Operations

Distribution channels2 records

Marketing channels4 records

WeMed product offering

Product offering

Core offering

WeMed designs and manufactures interventional medical imaging equipment and surgical robotics, including vascular angiography X-ray systems, mobile C-arms, coronary interventional surgery control systems, and interventional surgical robots, paired with an AI-based medical image processing software platform. Its products are used by hospitals and clinical centers to perform image-guided cardiovascular, neurointerventional, peripheral vascular, digestive, OB/GYN, and orthopedic procedures.

Product overview

WeMed is a medical technology company specializing in interventional robotics and medical imaging solutions. The product portfolio centers on interventional surgical control systems and medical vascular angiography X-ray machines across multiple series (Taikon太空, Pilot/Polaris, Phoenix, Elfinbot). The company also offers AI-powered image processing software (PrecisionSuit100) that integrates with their imaging hardware. Solution categories include cardiovascular imaging, neurointerventional imaging, digestive intervention, obstetrics/gynecology low-dose solutions, and orthopedic HD fluoroscopy. The flagship product ETcath200 represents their interventional robotics capability with intelligent guide wire control and resistance sensing.

Differentiator

Problem solved

Functional benefit

Products and services

  • ETcath200 Coronary Interventional Surgery Control System

Companies that use WeMed

Customer profile

Segments4 records

Ideal customer profiles1 record

WeMed technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature6 records

WeMed partnerships and signals

Strategic signal

Recent moves6 records

Expansion highlights4 records

WeMed competitors and assessment

Company assessment

Broad incumbents

  • Siemens Healthineers: Global leader in interventional imaging (Artis angiography systems) and acquired Corindus, a vascular interventional robotics company. WeMed competes head-to-head in the same interventional cardiology and angiography categories with its ETcath200 and Pilot/Taikon systems.
  • GE HealthCare: Operates the Innova interventional angiography platform and broad imaging portfolio. Directly competes with WeMed's Pilot3000 and Taikon series in hospital interventional suites, and competes on AI-enabled image processing capabilities.
  • Philips: Markets the Azurion image-guided therapy platform and integrated interventional cardiology suites. Competes with WeMed in angiography hardware, image guidance, and increasingly in procedural AI software.
  • Canon Medical Systems: Major angiography and interventional imaging manufacturer (Alphenix series). Directly competes with WeMed's interventional X-ray and angiography systems in hospital catheterization labs.

Direct peers

  • Stereotaxis: Developer of robotic magnetic navigation systems for cardiac ablation and interventional procedures. WeMed's ETcath200 robotic guide wire control system competes in the same interventional robotics category for catheter-based procedures.
  • Robocath: French developer of the R-One robotic platform for coronary angioplasty. WeMed's ETcath200 coronary interventional control system competes in the same vascular interventional robotics space.

Regional players

  • Neusoft Medical Systems: Chinese medical imaging manufacturer with angiography and CT product lines. Closest domestic competitor to WeMed's interventional imaging portfolio, competing for the same Chinese hospital customers.
  • United Imaging Healthcare: China-based high-end medical imaging and interventional equipment manufacturer. Competes with WeMed in angiography, mobile C-arms, and increasingly in AI-enabled imaging software for Chinese hospitals.
  • Mindray: Large Chinese medical device company with expanding imaging and interventional offerings. Competes with WeMed across multiple Chinese hospital departments and has greater scale in sales and service infrastructure.

Emerging players

  • Penumbra: US-based interventional thrombectomy and vascular robotics company (with REAL System). Competes with WeMed in neurovascular and peripheral vascular interventional procedures where image-guided therapy and robotic precision are key buying criteria.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

WeMed social profiles

Digital presence

WeMed compliance and trust

Trust signal

Compliance2 records

WeMed financial estimates

Financial estimate

Revenue estimate

Valuation estimate

WeMed leadership team

Management profile

Number of profiles

Profiles2 records

WeMed funding detail

Funding detail

Funding overview

Funding rounds4 records

Investors11 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

WeMed M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about WeMed

What does WeMed do?

WeMed designs and manufactures interventional medical imaging equipment and surgical robotics, including vascular angiography X-ray systems, mobile C-arms, coronary interventional surgery control systems, and interventional surgical robots, paired with an AI-based medical image processing software platform. Its products are used by hospitals and clinical centers to perform image-guided cardiovascular, neurointerventional, peripheral vascular, digestive, OB/GYN, and orthopedic procedures.

Is WeMed a public or private company?

WeMed is a private company. It is classified as venture growth investor backed and is currently operating.

When was WeMed founded?

WeMed was founded in 2014. It employs 1 to 10 people.

Where is WeMed based?

WeMed is headquartered in Beijing, China, in the Asia region.

Who are WeMed's main competitors?

Broad incumbents on record are Siemens Healthineers, GE HealthCare, Philips and Canon Medical Systems. Direct peers are Stereotaxis and Robocath. Regional players are Neusoft Medical Systems, United Imaging Healthcare and Mindray. Penumbra is listed as an emerging player.

Does WeMed have an API?

No public API is recorded for WeMed.

What industry is WeMed in?

WeMed's product category is Interventional Medical Imaging Equipment. Its primary akta.pro industry code is HLAHADAF, Surgical Robotics & Computer-Assisted Surgery Platforms, with a secondary code of HLAHAEAL, Surgical Navigation, Robotics & Patient-Matched Instrumentation (Ortho/Spine). Its NAICS code is 339112 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals